Oltipraz treatment in experimental schistosomiasis mansoni:VII. Effect of high dose oral therapy on alkaline phosphatase level in livers of infected mice.
Biochemical estimation of alkaline phosphatase (AP) in livers of mice experimentally infected with the Egyptian strain of S. mansoni before and after oltipraz treatment was carried out. The drug was given in a single oral dose of 500 mg/kg body weight. The results revealed that the drug led to gradual reduction in the AP mean level after 20 and 30 days from treatment. This was then followed by rise in the enzyme mean level, after 60 days. The drug also caused significant reduction in the AP mean level in livers of the drug control group of mice after 5 and 20 days from oltipraz administration in comparison normal uninfected controls. These findings might be attributed to a hepatocytotoxic effect of the drug.
Aboul-Atta
A M
AM
Department of Parasitology, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt.
Hassan
Z A
ZA
Awadallah
F E
FE
el-Ahl
S S
SS
Hamdy
B H
BH
D000469:Alkaline Phosphatase / Q000032:analysis*; D000818:Animals; D008099:Liver / Q000201:enzymology*; D008297:Male; D051379:Mice; D011719:Pyrazines / Q000009:adverse effects / Q000627:therapeutic use*; D012555:Schistosomiasis mansoni / Q000188:drug therapy*; D012556:Schistosomicides / Q000009:adverse effects / Q000627:therapeutic use*; D013871:Thiones; D013876:Thiophenes
D011719:Pyrazines; D012556:Schistosomicides; D013871:Thiones; D013876:Thiophenes; C026209:oltipraz; D000469:Alkaline Phosphatase